Biocompatibility of Chitosan Carriers with Application in Drug Delivery
Chitosan is one of the most used polysaccharides in the design of drug delivery strategies for administration of either biomacromolecules or low molecular weight drugs. For these purposes, it is frequently used as matrix forming material in both nano and micron-sized particles. In addition to its in...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-09-01
|
Series: | Journal of Functional Biomaterials |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-4983/3/3/615 |
id |
doaj-1e0f9c9b75cf455d9291f71210472e03 |
---|---|
record_format |
Article |
spelling |
doaj-1e0f9c9b75cf455d9291f71210472e032020-11-24T23:46:09ZengMDPI AGJournal of Functional Biomaterials2079-49832012-09-013361564110.3390/jfb3030615Biocompatibility of Chitosan Carriers with Application in Drug DeliveryAna GrenhaSusana RodriguesCarmen Remuñán LópezMarita DionísioChitosan is one of the most used polysaccharides in the design of drug delivery strategies for administration of either biomacromolecules or low molecular weight drugs. For these purposes, it is frequently used as matrix forming material in both nano and micron-sized particles. In addition to its interesting physicochemical and biopharmaceutical properties, which include high mucoadhesion and a great capacity to produce drug delivery systems, ensuring the biocompatibility of the drug delivery vehicles is a highly relevant issue. Nevertheless, this subject is not addressed as frequently as desired and even though the application of chitosan carriers has been widely explored, the demonstration of systems biocompatibility is still in its infancy. In this review, addressing the biocompatibility of chitosan carriers with application in drug delivery is discussed and the methods used in vitro and in vivo, exploring the effect of different variables, are described. We further provide a discussion on the pros and cons of used methodologies, as well as on the difficulties arising from the absence of standardization of procedures.http://www.mdpi.com/2079-4983/3/3/615biocompatibilitychitosancytotoxicitygenotoxicitymicroparticlesnanoparticles |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ana Grenha Susana Rodrigues Carmen Remuñán López Marita Dionísio |
spellingShingle |
Ana Grenha Susana Rodrigues Carmen Remuñán López Marita Dionísio Biocompatibility of Chitosan Carriers with Application in Drug Delivery Journal of Functional Biomaterials biocompatibility chitosan cytotoxicity genotoxicity microparticles nanoparticles |
author_facet |
Ana Grenha Susana Rodrigues Carmen Remuñán López Marita Dionísio |
author_sort |
Ana Grenha |
title |
Biocompatibility of Chitosan Carriers with Application in Drug Delivery |
title_short |
Biocompatibility of Chitosan Carriers with Application in Drug Delivery |
title_full |
Biocompatibility of Chitosan Carriers with Application in Drug Delivery |
title_fullStr |
Biocompatibility of Chitosan Carriers with Application in Drug Delivery |
title_full_unstemmed |
Biocompatibility of Chitosan Carriers with Application in Drug Delivery |
title_sort |
biocompatibility of chitosan carriers with application in drug delivery |
publisher |
MDPI AG |
series |
Journal of Functional Biomaterials |
issn |
2079-4983 |
publishDate |
2012-09-01 |
description |
Chitosan is one of the most used polysaccharides in the design of drug delivery strategies for administration of either biomacromolecules or low molecular weight drugs. For these purposes, it is frequently used as matrix forming material in both nano and micron-sized particles. In addition to its interesting physicochemical and biopharmaceutical properties, which include high mucoadhesion and a great capacity to produce drug delivery systems, ensuring the biocompatibility of the drug delivery vehicles is a highly relevant issue. Nevertheless, this subject is not addressed as frequently as desired and even though the application of chitosan carriers has been widely explored, the demonstration of systems biocompatibility is still in its infancy. In this review, addressing the biocompatibility of chitosan carriers with application in drug delivery is discussed and the methods used in vitro and in vivo, exploring the effect of different variables, are described. We further provide a discussion on the pros and cons of used methodologies, as well as on the difficulties arising from the absence of standardization of procedures. |
topic |
biocompatibility chitosan cytotoxicity genotoxicity microparticles nanoparticles |
url |
http://www.mdpi.com/2079-4983/3/3/615 |
work_keys_str_mv |
AT anagrenha biocompatibilityofchitosancarrierswithapplicationindrugdelivery AT susanarodrigues biocompatibilityofchitosancarrierswithapplicationindrugdelivery AT carmenremunanlopez biocompatibilityofchitosancarrierswithapplicationindrugdelivery AT maritadionisio biocompatibilityofchitosancarrierswithapplicationindrugdelivery |
_version_ |
1725494346784964608 |